Skip to main content
OpenTrials
Completed

NCT Number: NCT02782455

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease

Haemorrhoids are vascular cushions in the anal canal that help in the control of stool. When inflamed they become pathological and may present with protrusion and bleeding. A randomized, triple blind , controlled study will be conducted to compare the efficacy of calcium dobesilate against flavanoids in the management of early haemorrhoidal disease.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Hemorrhoids Cardiovascular Diseases Digestive System Diseases Gastrointestinal Diseases Intestinal Diseases Rectal Diseases Vascular Diseases

Age range

13 year–80 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 4

Primary location

Services Hospital Lahore

Lahore, Punjab Province, 54000, Pakistan

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Grade I and Grade II hemorrhoids

Exclusion criteria

  • CLD
  • colorectal/ anorectal Malignancy
  • self medication
  • local Quack Hakeem medication
  • pregnancy

Treatment and study plan

Flavonoids

Drug

Daflon is administered

Other names: Daflon

CDobi

Drug

Calcium dobesylate is administered

Other names: dobesilate

Primary outcomes

  1. Frequency of occurrence of rectal bleeding after usage of drug

    Time frame: 1 weeks

    After the patients will be given the two drugs they will be followed for the frequency of occurrence of rectal bleeding till two weeks

Secondary outcomes

  1. regression of hemorrhoids

    Time frame: 1 weeks

    Patients will under gone per rectal examination and proctoscopy to look for grades of hemorrhoids whether its has decreased or increased.

Sponsors and collaborators

Lead sponsor

Services Hospital, Lahore

Other Gov

Registry information

Official study title

Calcium Dobesilate vs Flavonoids for the Treatment of Early Hemorrhoidal Disease a Randomised Triple Blind Controlled Trial

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
May 25, 2016
Registry last updated
Dec 26, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.